Google for Startups Latino Founders Fund and Black Founders Fund announced their latest cohorts and two Houston founders made the cut. Photo via Getty Images

Two Houston startups have received funding from Google in the latest round of the tech giant's Founders Funds grants.

That's Clutch, a creator economy platform that connects emerging brands with its network of digital marketing professionals, was named to the second cohort of Google for Startups Latino Founders Fund. And SmartWiz, an AI enabled IRS approved tax professional software, was named to Google for Startups' sixth Black Founders Fund.

Both startups will receive $150,000 in non-dilutive funds, mentorship, access to programs, and other resources like sales training, investor prep, mental health coaching at no cost.

Madison Long, CEO and Co-founder at That’s Clutch said the funds will help That's Clutch build upon it's go to market strategy and sales strategy, among other benefits.

“The Google for Startups support network has introduced me to so many valuable connections across the country,” Long said in a statement. “Being selected for the Founders Fund is not only an honor but a massive resource as we take Clutch to the next level."

Madison Long of That's Clutch joins the 448 founders who have been supported by Google's funds. Photo courtesy

Bre Johnson — who is based in Houston, while her company SmartWiz is headquartered in Birmingham, Alabama — told Innovation Map that the funds and partnership with Google will help her company scale and improve their AI platform for the tax industry.

"This funding (gives) us the ability to build our product faster, scale our organization and really take over the digital space with improved support on how we market our software using Google SEO," she says. "We will be giving our users a more innovative, fun and revolutionary approach to tax preparation while ensuring every single person who gets their taxes done by someone using our software will have an improved experience every single year."

"Being black founders, and even me being a woman, we don't take this opportunity for granted because we know that it is a blessing," she continues.

Bre Johnson of SmartWiz also received funding from Google. Photo courtesy

That's Clutch and SmartWiz are among the 448 founders Google has backed through its Founder Funds globally since 2020. Five other Texas-based startups received funding this round, according to an announcement.

Other Texas startups include:

Last year, three Houston startups were named to the inaugural Google for Startups Latino Founders Fund: AnswerBite, Boxes and Ease. That same year, ChurchSpace and Enrichly were named to the Google for Startups Black Founders Fund.

Ease, a health care fintech platform founded by Mario Amaro in 2018, was also named to Amazon's WS Impact Accelerator Latino Founders Cohort, part of Amazon's $30 million commitment to supporting underrepresented startup founders, earlier this summer.

Google has named its first class of Latino entrepreneurs for its inclusive fund. Photo via Getty Images

Google taps 3 Houston Latino-led startups for inaugural non-equity cash awards

Money moves

Google announced today that it has selected 50 companies for the inaugural cohort of the Google for Startups Latino Founders Fund.

Nine startups in Texas have been selected — and three of them are bases in Houston. Each company will receive an equity-free $100,000 investment, as well as programming and support from Google, mentorship from technical and business experts, access to free mental health therapy, and more.

The Houston companies selected were:

  • AnswerBite, which supports marketing enterprise teams with social proof videos and customer insights in minutes and has over 300 clients
  • Boxes, which creates devices that combine physical and digital technology to democratize convenient, affordable, and sustainable retail
  • Ease, financial practice operations platform that helps clinicians build new practices from the ground up

“Being selected to attend the inaugural cohort of Google for Startups Latino Founders Fund gets us one step closer towards completing our mission of increasing healthcare access for Black and Latino communities,” says Dr. Mario Amaro, founder and CEO of Ease, in a news release. “The support and excitement that Google continues to have for small business gives us so much confidence in the future of private practice and clinician entrepreneurship.”

The program was founded to shrink the gap in opportunities and wealth for Latinos in the business community who are disproportionately affected by a lack of access to funding.

“We are excited to support these talented Latino entrepreneurs as they build innovative solutions and solve tough problems,” says Daniel Navarro, US marketing lead for Google for Startups, in the release. “I hope the launch of our inaugural Google for Startups Latino Founders Fund not only catalyzes the growth of these incredible Latino-led startups, but also inspires other Latino entrepreneurs, and ultimately generates wealth within the community."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.


Houston researchers make headway on affordable, sustainable sodium-ion battery

Energy Solutions

A new study by researchers from Rice University’s Department of Materials Science and NanoEngineering, Baylor University and the Indian Institute of Science Education and Research Thiruvananthapuram has introduced a solution that could help develop more affordable and sustainable sodium-ion batteries.

The findings were recently published in the journal Advanced Functional Materials.

The team worked with tiny cone- and disc-shaped carbon materials from oil and gas industry byproducts with a pure graphitic structure. The forms allow for more efficient energy storage with larger sodium and potassium ions, which is a challenge for anodes in battery research. Sodium and potassium are more widely available and cheaper than lithium.

“For years, we’ve known that sodium and potassium are attractive alternatives to lithium,” Pulickel Ajayan, the Benjamin M. and Mary Greenwood Anderson Professor of Engineering at Rice, said in a news release. “But the challenge has always been finding carbon-based anode materials that can store these larger ions efficiently.”

Lithium-ion batteries traditionally rely on graphite as an anode material. However, traditional graphite structures cannot efficiently store sodium or potassium energy, since the atoms are too big and interactions become too complex to slide in and out of graphite’s layers. The cone and disc structures “offer curvature and spacing that welcome sodium and potassium ions without the need for chemical doping (the process of intentionally adding small amounts of specific atoms or molecules to change its properties) or other artificial modifications,” according to the study.

“This is one of the first clear demonstrations of sodium-ion intercalation in pure graphitic materials with such stability,” Atin Pramanik, first author of the study and a postdoctoral associate in Ajayan’s lab, said in the release. “It challenges the belief that pure graphite can’t work with sodium.”

In lab tests, the carbon cones and discs stored about 230 milliamp-hours of charge per gram (mAh/g) by using sodium ions. They still held 151 mAh/g even after 2,000 fast charging cycles. They also worked with potassium-ion batteries.

“We believe this discovery opens up a new design space for battery anodes,” Ajayan added in the release. “Instead of changing the chemistry, we’re changing the shape, and that’s proving to be just as interesting.”

---

This story originally appeared on EnergyCapitalHTX.com.